OPCH:NASDAQ
Option Care Health Inc
$31.22
arrow_downward
-0.22%(-0.070) 1D
$31.22
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 23, 4:00:00 PM GMT-4 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for OPCH...
Open
$31.31
High
$31.33
Low
$31.22
Mkt. cap
4.68B
Avg. vol.
5.70M
Volume
2.65M
P/E ratio
23.62
52-wk high
$36.79
52-wk low
$18.02
EPS
$1.32
Beta
0.58
Shares outstanding
149.78M
No. of employees
7K
Open
$31.31
High
$31.33
Low
$31.22
Mkt. cap
4.68B
Avg. vol.
5.70M
Volume
2.65M
P/E ratio
23.62
52-wk high
$36.79
52-wk low
$18.02
EPS
$1.32
Beta
0.58
Shares outstanding
149.78M
No. of employees
7K
News stories
From web sources and news partners
Morningstar
·
3 days ago
Are BRZE, SLN, OPCH, RXO Obtaining Fair Deals for their Shareholders?
About Option Care Health Inc
CEO-
Employees7.4K
Founded1996
HeadquartersBannockburn, Illinois, United States
SectorHealth care provider
Websiteoptioncarehealth.com
Analyst ratings
Based on 10 analysts giving stock ratings to OPCH in the past 3 months
Hold
Buy
2
Hold
8
Sell
0
12-month forecast
Based on 10 Wall Street analysts offering 12 month price targets for OPCH in the last 3 months.
Highest
Current $31.22
$33.00 (+5.70%)
Average
$28.74 (-7.94%)
Lowest
$23.00 (-26.33%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Erin Wright Morgan Stanley | Hold | Downgraded | $32.05 | +2.7% | 10/12/2026 |
Lisa Gill J.P. Morgan | Hold | Downgraded | $33.00 | +5.7% | 10/10/2026 |
A.J. Rice UBS | Hold | Downgraded | $32.05 | +2.7% | 10/09/2026 |
Michael Petusky Barrington | Hold | Downgraded | - | - | 10/07/2026 |
Brian Tanquilut Jefferies | Hold | Downgraded | $32.05 | +2.7% | 10/06/2026 |
David S Macdonald Truist Financial | Buy | Maintained | - | - | 10/06/2026 |
Matt Larew William Blair | Buy | Maintained | - | - | 10/06/2026 |
Charles Rhyee TD Cowen | Hold | Maintained | $23.00 | -26.3% | 08/02/2026 |
Joanna Gajuk Bank of America Securities | Hold | Reiterated | $25.00 | -19.9% | 07/29/2026 |
Pito Chickering Deutsche Bank | Hold | Downgraded | $24.00 | -23.1% | 07/30/2026 |
Kyle Evans Stephens | Hold | Downgraded | $24.00 | -23.1% | 07/17/2026 |
Raj Kumar CFA Stephens | Hold | Downgraded | $24.00 | -23.1% | 07/17/2026 |
Scott Fidel Goldman Sachs | Hold | Initiated | $22.00 | -29.5% | 06/08/2026 |
Constantine Davides Citizens JMP | Buy | Maintained | $32.00 | +2.5% | 04/30/2026 |
Unknown Analyst Jefferies | Buy | Maintained | $43.00 | +37.7% | 03/25/2026 |
Next call in 6 days
Thu, Oct 29, 2:30 PM
Fiscal period
Q3 2026
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
- / $0.49
Revenue / Est. (USD)
- / 1.48B
Fiscal Q3 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 1.44B | 1.47B | 1.35B | 1.44B |
Cost of goods sold | 1.16B | 1.18B | 1.09B | 1.18B |
Cost of revenue | 1.16B | 1.18B | 1.09B | 1.18B |
Research and development expenses | - | - | - | - |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 172.10M | 172.14M | 174.56M | 164.66M |
Operating expense | 188.40M | 191.40M | 189.47M | 182.11M |
Total operating expenses | 1.35B | 1.37B | 1.28B | 1.36B |
Operating income | 84.51M | 91.50M | 72.54M | 85.14M |
Other non operating income | 3.37M | -6.00M | 1.78M | -532.00K |
EBT including unusual items | 68.97M | 81.52M | 61.00M | 73.99M |
EBT excluding unusual items | 73.67M | 81.52M | 61.00M | 73.99M |
Income tax expense | 17.15M | 23.01M | 15.66M | 20.07M |
Effective tax rate | 24.87% | 28.23% | 25.67% | 27.13% |
Other operating expenses | - | - | - | - |
Net income | 51.82M | 58.50M | 45.34M | 53.91M |
Net profit margin | 3.61% | 3.99% | 3.36% | 3.74% |
Earnings per share | 0.45 | 0.46 | 0.40 | 0.45 |
Interest and investment income | - | - | - | - |
Interest expense | -16.39M | -6.09M | -15.01M | -12.32M |
Net interest expenses | -16.39M | -6.09M | -15.01M | -12.32M |
Depreciation and amortization charges | 16.29M | 19.26M | 14.91M | 17.45M |
EBITDA | 101.56M | 111.82M | 88.20M | 103.52M |
Gain or loss from assets sale | - | - | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1